Status:

COMPLETED

Microwave Therapy for Treatment of Precancerous Actinic Keratoses

Lead Sponsor:

University of Dundee

Collaborating Sponsors:

Emblation Limited

Conditions:

Actinic Keratoses

Precancerous Skin Lesion

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This is a two-stage feasibility study to determine if focussed microwave energy is a suitable treatment for Actinic Keratoses (AK). The two study stages are as follows: Stage 1: To determine the el...

Detailed Description

This study is a collaboration between the University of Dundee, NHS Tayside and Emblation Ltd, funded by Innovate UK. Emblation is a Scottish based Small Medium sized Enterprise (SME) and is an establ...

Eligibility Criteria

Inclusion

  • Male or female participants
  • Age 18 years and over
  • Clinical diagnosis of precancerous Actinic Keratosis made by a dermatologist
  • Able to perform study assessments

Exclusion

  • Inability to give informed consent
  • Implantable Cardioverter-defibrillator (ICD), pacemaker or other implantable device
  • Metal implants at site of treatment
  • Known allergy or intolerance to microwave therapy
  • Unstable co-morbidities (cardiovascular disease, active malignancy, vasculopathy, inflammatory arthritis) which, in the opinion of the Chief Investigator (CI), would make the patient unsuitable to be enrolled in the study.
  • Individuals who are immunosuppressed (organ transplant recipients, haematologic malignancies, HIV).
  • Individuals will not be enrolled to the study if they are participating in the clinical phase of another interventional trial or have done so within the last 30 days. Individuals who are participating in the follow-up phase of another interventional trial, or who are enrolled in an observational study, will be co-enrolled where the CIs of each study agree that it is appropriate.

Key Trial Info

Start Date :

March 7 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 28 2019

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT03483935

Start Date

March 7 2018

End Date

February 28 2019

Last Update

March 6 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

NHS Tayside

Dundee, United Kingdom, DD1 9SY